Qserve Group (Netherlands)

Recent papers from Qserve Group (Netherlands)

1. TR-FRET between engineered nanobodies reveals the existence of endogenous CXCR4 oligomersCommunications Biology · 2025
2. Genetic Engineering of VHH Antibody Fragments for Efficient Site-Specific Conjugation to PolysaccharidesBioconjugate Chemistry · 2025
3. Indium-111-Labeled Single-Domain Antibody for In Vivo CXCR4 Imaging Using Single-Photon Emission Computed TomographyBioconjugate Chemistry · 2025
4. Constitutive activity of an atypical chemokine receptor revealed by inverse agonistic nanobodies2024
5. The development of single-domain VHH nanobodies that target the Candida albicans cell surfaceMicrobiology Spectrum · 2024
6. Multivalent CXCR4-targeting nanobody formats differently affect affinity, receptor clustering, and antagonismBiochemical Pharmacology · 2024
7. Nanobody-liposomes as novel cancer vaccine platform to efficiently stimulate T cell immunityInternational Journal of Pharmaceutics · 2024
8. Nanobody-mediated neutralization of candidalysin prevents epithelial damage and inflammatory responses that drive vulvovaginal candidiasis pathogenesismBio · 2024
9. Molecular characterization of the CXCR4 / CXCR7 axis in germ cell tumors and its targetability using nanobody-drug-conjugatesExperimental Hematology and Oncology · 2023
10. Inhibition of cleavage of human complement component C5 and the R885H C5 variant by two distinct high affinity anti-C5 nanobodiesJournal of Biological Chemistry · 2023
11. NanoB2 to monitor interactions of ligands with membrane proteins by combining nanobodies and NanoBRETCell Reports Methods · 2023
12. Inhibition of cleavage of human complement component C5 and the R885H C5 variant by two distinct high affinity anti-C5 nanobodies2023
13. Candidalysin Is the Hemolytic Factor of Candida albicansToxins · 2022
14. Fluorescently tagged nanobodies and NanoBRET to study ligand-binding and agonist-induced conformational changes of full-length EGFR expressed in living cellsFrontiers in Immunology · 2022
15. Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodiesScientific Reports · 2022
16. Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector FunctionsFrontiers in Immunology · 2022
17. Selective targeting of ligand-dependent and -independent signaling by GPCR conformation-specific anti-US28 intrabodiesNature Communications · 2021
18. Candidalysin delivery to the invasion pocket is critical for host epithelial damage induced byCandida albicansCellular Microbiology · 2021
19. Viral G Protein–Coupled Receptors: Attractive Targets for Herpesvirus-Associated DiseasesPharmacological Reviews · 2021
20. Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine designScientific Reports · 2021